Literature DB >> 15681899

Functional characterization of single nucleotide polymorphisms with amino acid substitution in CYP1A2, CYP2A6, and CYP2B6 found in the Japanese population.

Masahiko Iwasaki1, Yoshinobu Yoshimura, Satoru Asahi, Kimitoshi Saito, Shuichi Sakai, Shigemichi Morita, Osamu Takenaka, Toshio Inoda, Eiji Kashiyama, Akinori Aoyama, Takeshi Nakabayashi, Satoshi Omori, Takashi Kuwabara, Takashi Izumi, Kouichi Nakamura, Kaoru Takanaka, Yukiharu Nakayama, Mitsuaki Takeuchi, Hideki Nakamura, Shunichi Kametani, Yoshiaki Terauchi, Takanori Hashizume, Sekio Nagayama, Toshiyuki Kume, Meguru Achira, Hiroyuki Kawai, Takashi Kawashiro, Akio Nakamura, Yasuhiro Nakai, Akira Kagayama, Toshifumi Shiraga, Takuro Niwa, Takuya Yoshimura, Jun Morita, Fukuichi Ohsawa, Masato Tani, Nobuo Osawa, Keiichi Ida, Kiyoshi Noguchi.   

Abstract

As a part of the studies conducted by the Pharma SNPs Consortium (PSC), the enzyme activities of CYP1A2, CYP2A6 and CYP2B6 variants with altered amino acids as a result of single nucleotide polymorphisms (SNPs) found among the Japanese population were analyzed under a unified protocol using the same lots of reagents by the laboratories participating in the PSC. Mutations in CYP1A2, CYP2A6 and CYP2B6 were introduced by site-directed mutagenesis and the wild type and mutated CYP molecules were expressed in Escherichia coli. The expressed cytochrome P450s were purified and the enzyme activities were measured in reconstitution systems. CYP1A2 and CYP1A2Gln478His did not show any differences in 7-ethoxyresorufin O-deethylase activity. CYP2A6 and CYP2A6Glu419Asp metabolized coumarin to form 7-hydroxycoumarin in a similar manner, whereas CYP2A6Ile471Thr showed low activity compared to the wild-type CYP2A6. CYP2B6, CYP2B6Pro167Ala and CYP2B6Arg487Cys showed the same activity for 7-ethoxy-4-triflouromethyl-coumarin O-deethylation. However, CYP2B6Gln172His was roughly twice as active as CYP2B6 and the other CYP2B6 variants for 7-ethoxy-4-triflouromethylcoumarin O-deethylation activity. Although higher inter- and intra-laboratory variations were observed for the calculated Km and V(max) values because the studies were conducted in several different laboratories, the degree of variations was reduced by the increased number of analyses and the adoption of a simple analysis system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15681899     DOI: 10.2133/dmpk.19.444

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  5 in total

1.  Prevalence of CYP2B6 alleles in malaria-endemic populations of West Africa and Papua New Guinea.

Authors:  Rajeev K Mehlotra; Mark N Ziats; Moses J Bockarie; Peter A Zimmerman
Journal:  Eur J Clin Pharmacol       Date:  2006-02-28       Impact factor: 2.953

2.  N-7-Alkyl-2'-Deoxyguanosine as surrogate biomarkers for N-nitrosamine exposure in human lung.

Authors:  Natarajan Ganesan; Shunji Kato; Elise D Bowman; Peter G Shields
Journal:  Int J Canc Prev       Date:  2007

Review 3.  The evolving role of drug metabolism in drug discovery and development.

Authors:  Lilian G Yengi; Louis Leung; John Kao
Journal:  Pharm Res       Date:  2007-03-01       Impact factor: 4.580

4.  A modeling approach to evaluate the balance between bioactivation and detoxification of MeIQx in human hepatocytes.

Authors:  Victorien Delannée; Sophie Langouët; Nathalie Théret; Anne Siegel
Journal:  PeerJ       Date:  2017-09-01       Impact factor: 2.984

5.  Prevalence of poor and rapid metabolizers of drugs metabolized by CYP2B6 in North Indian population residing in Indian national capital territory.

Authors:  Ekta Varshney; Nilanjan Saha; Monika Tandon; Vikesh Shrivastava; Shakir Ali
Journal:  Springerplus       Date:  2012-10-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.